Market Cap

Neuronetics, Inc. Market Capitalization:

$98.6 Million

USD as of Jan. 1, 2026

business Neuronetics, Inc. Company Profile

Neuronetics, Inc. Main Stock Listing

NASDAQ: STIM

Market Capitalization History of Neuronetics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Neuronetics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $98.6 M -27.37%
Jan. 1, 2025 $135.8 M 56.97%
Jan. 1, 2024 $86.5 M -48.49%
Jan. 1, 2023 $168.0 M 62.29%
Jan. 1, 2022 $103.5 M -79.69%
Jan. 1, 2021 $509.7 M 385.67%
Jan. 1, 2020 $104.9 M -78.80%
Jan. 1, 2019 $494.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Neuronetics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Neuronetics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: STIM

Stock: FSX: NRC

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.